Oxycodone ADF
Total Payments
$177,863
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $177,863 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $177,863 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Single Dose Crossover Comparative Bioavailability Study of Oxycodone 40mg Extended-Release Tablets in Healthy Male and Female Volunteers/Fasting State (ANL-P0-462) | Amneal Pharmaceuticals LLC | $177,863 | 0 |
Top Doctors Receiving Payments for Oxycodone ADF
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | — | $177,863 | 3 |
Ad
Manufacturing Companies
- Amneal Pharmaceuticals LLC $177,863
Product Information
- Type Drug
- Total Payments $177,863
- Total Doctors 0
- Transactions 3
About Oxycodone ADF
Oxycodone ADF is a drug associated with $177,863 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2017 to 2017. In 2017, $177,863 was paid across 3 transactions to 0 doctors.
The most common payment nature for Oxycodone ADF is "Unspecified" ($177,863, 100.0% of total).
Oxycodone ADF is associated with 1 research study, including "Single Dose Crossover Comparative Bioavailability Study of Oxycodone 40mg Extended-Release Tablets in Healthy Male and Female Volunteers/Fasting State (ANL-P0-462)" ($177,863).